VOICED : Países europeos lanzan campaña de vacunación de niños

VOICED : Países europeos lanzan campaña de vacunación de niños

Assessment

Interactive Video

Science, Social Studies, Health

6th - 8th Grade

Hard

Created by

Quizizz Content

FREE Resource

European countries, including Spain and Germany, have started vaccinating children aged 5-11 against COVID-19 using the Pfizer-BioNTech vaccine. The demand for vaccination appointments is high, with slots filling up quickly. Ursula von der Leyen, President of the European Commission, has expressed concerns about the rapid spread of the Omicron variant, which is expected to become dominant in Europe by mid-January. To combat this, many countries are administering booster shots, and the European Medicines Agency has approved the Johnson & Johnson vaccine as a booster for adults over 18.

Read more

5 questions

Show all answers

1.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

Which age group is being targeted for COVID-19 vaccinations in the discussed European countries?

Seniors aged 65 and above

Adults aged 18 to 30

Teenagers aged 12 to 17

Children aged 5 to 11

2.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What was the response to the opening of vaccination slots for children?

Few slots were filled

All slots were filled immediately

Slots remained mostly empty

Slots were filled gradually over time

3.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What is Ursula von der Leyen's main concern regarding the Omicron variant?

It is less infectious than previous variants

It has no impact on vaccination efforts

It could lead to increased holiday disruptions

It is not spreading in Europe

4.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What is the expected timeline for Omicron to become the dominant variant in Europe?

By mid-March

By the end of February

By mid-January

By the end of December

5.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

Which vaccine has been approved as a booster for adults over 18 by the European Medicines Agency?

AstraZeneca

Johnson & Johnson

Pfizer

Moderna